Acetabular avascular necrosis following high-dose steroid treatment and chemotherapy for leukemia: Computer tomography analysis of treatment with impaction bone grafting

被引:3
|
作者
Chou, Daud Tai Shan [1 ,2 ]
Taylor, Mark [3 ]
Baker, Markus [4 ]
Studer, Patrick [5 ]
Solomon, Lucian Bogdan [1 ,2 ]
机构
[1] Univ Adelaide, Discipline Orthoped & Trauma & Ctr Orthopaed & Tr, Adelaide, SA 5000, Australia
[2] Royal Adelaide Hosp, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[3] Flinders Univ S Australia, Coll Sci & Engn, Med Device Res Inst, 1284 South Rd, Adelaide, SA 5042, Australia
[4] South West London Elect Orthopaed Ctr & Epsom & S, Dorking Rd, Epsom KT18 7EG, Surrey, England
[5] Orthopadie Unfallchirurg Staphanshorn AG, Orthopaed & Trauma, CH-9016 St Gallen, Switzerland
关键词
Avascular necrosis; Acute lymphoblastic leukemia; Chemotherapy; Corticosteroid; Impaction bone grafting; Computer tomography; FEMORAL-HEAD; OSTEONECROSIS; HIP; THERAPY; RISK;
D O I
10.1007/s00256-019-03244-7
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Avascular necrosis (AVN) of the bone is thought to be a serious complication of treatment for acute lymphoblastic leukemia (ALL). The acetabulum is an unusual area to be affected by AVN, and there are currently no reports of successful joint salvage procedures found in the literature. We present a case of a 20-year-old man with ALL who was diagnosed with debilitating AVN of both acetabula 2 years following initial diagnosis of ALL and treatment with a multi-agent chemotherapy regimen including high-dose corticosteroids. After unsuccessful treatment with bisphosphonate therapy, the acetabular AVN underwent bilateral curettage and impaction bone grafting to prevent collapse of subchondral fractures with the hope of salvaging both hip joints. Computer tomography (CT) of the AVN affected areas, pre- and post-bone impaction grafting, demonstrated healing of the subchondral fractures and a doubling of bone density that was maintained at 2 years after surgery. The patient resumed full weight-bearing at 3 months after first surgery, continues to ambulate unrestricted, and remains pain free 3 years post-surgery.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 50 条
  • [41] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF SMALL CELL LUNG-CARCINOMA
    FARHA, P
    SPITZER, G
    VALDIVIESO, M
    DICKE, KA
    ZANDER, A
    DHINGRA, HM
    MINNHAAR, G
    VELLEKOOP, L
    VERMA, DS
    UMSAWASDI, T
    CHIUTEN, D
    CANCER, 1983, 52 (08) : 1351 - 1355
  • [42] TREATMENT OF ADVANCED ESTHESIONEUROBLASTOMA WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A CASE-REPORT
    OCONOR, GT
    DRAKE, CR
    JOHNS, ME
    CAIL, WS
    WINN, HR
    NISKANEN, E
    CANCER, 1985, 55 (02) : 347 - 349
  • [43] TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BRICE, P
    GISSELBRECHT, C
    FERME, C
    LEPAGE, E
    BARUCHEL, A
    MAROLLEAU, JP
    GEROTA, O
    BOIRON, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (03): : 267 - 272
  • [44] Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma
    Fenk, R
    Hoyer, B
    Steidl, U
    Kondakci, M
    Graef, T
    Heuk, R
    Ruf, L
    Strupp, C
    Neumann, F
    Rohr, UP
    Hildebrandt, B
    Haas, R
    Kobbe, G
    LEUKEMIA, 2005, 19 (01) : 156 - 159
  • [45] Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma
    R Fenk
    B Hoyer
    U Steidl
    M Kondakci
    T Graef
    R Heuk
    L Ruf
    C Strupp
    F Neumann
    U-P Rohr
    B Hildebrandt
    R Haas
    G Kobbe
    Leukemia, 2005, 19 : 156 - 159
  • [46] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS - PRELIMINARY-RESULTS USING HIGH-DOSE CYTARABINE (HDC) IN CONSOLIDATION CHEMOTHERAPY OR IN CONDITIONING TREATMENT PRIOR TO BONE-MARROW TRANSPLANTATION (BMT)
    CHAMPLIN, R
    JACOBS, A
    HO, W
    WINSTON, D
    GALE, RP
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 409 - 409
  • [47] A survival analysis and treatment outcomes of 131 cases of osteosarcoma treated with high-dose methotrexate multidrug chemotherapy
    Xu, Ye-Feng
    Jiang, Shen-Jun
    Wang, Yi-Qing
    Yao, Yong-Wei
    Liu, Yun-Xia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8465 - 8473
  • [48] TREATMENT OF SMALL CELL BRONCHOGENIC (SCBC) WITH HIGH-DOSE CHEMOTHERAPY (CT) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    FARHA, P
    SPITZER, G
    VALDIVIESO, M
    ZANDER, A
    VERMA, D
    MINNHAAR, G
    VELLEKOOP, L
    DICKE, K
    BODEY, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 496 - 496
  • [49] MALIGNANT-MELANOMA - TREATMENT WITH HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT
    SHEA, TC
    ANTMAN, KH
    EDER, JP
    ELIAS, A
    PETERS, WP
    SCHRYBER, S
    HENNER, WD
    SCHOENFELD, DA
    SCHNIPPER, LE
    FREI, E
    ARCHIVES OF DERMATOLOGY, 1988, 124 (06) : 878 - 884
  • [50] Treatment of germ cell cancer patients who relapse after high-dose chemotherapy and autologous bone marrow transplantation
    Sarosiek, T.
    Rzepecki, P.
    Szczylik, C.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S94 - S95